Aerovate Therapeutics

-$1.99 (-11.77%) As of 4:10 PM UTC today

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell AVTE and other ETFs, options, and stocks.

About AVTE

Aerovate Therapeutics, Inc. is a biotechnology company which engages in the development of drugs for rare cardiopulmonary disease. It focus on advancing AV-101, dry powder inhaled formulation of imatinib for the treatment of pulmonary arterial hypertension.

CEO
Timothy P. Noyes
Employees
—
Headquarters
Boston, Massachusetts
Founded
2018

AVTE Key Statistics

Market Cap
363.78M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
256.25K
High Today
$16.57
Low Today
$14.33
Open Price
$15.71
Volume
128.79K
52 Week High
$29.43
52 Week Low
$11.40

AVTE Earnings

-$23.80
-$15.87
-$7.93
$0.00
Q2 FY21
Q3 FY21
Estimated
— per share
Actual
Expected Nov 15, Pre-Market
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure